Copyright
©The Author(s) 2026.
World J Gastrointest Oncol. Jan 15, 2026; 18(1): 114924
Published online Jan 15, 2026. doi: 10.4251/wjgo.v18.i1.114924
Published online Jan 15, 2026. doi: 10.4251/wjgo.v18.i1.114924
Figure 1 The main information of the published article.
DDR: DNA damage response; ESCC: Esophageal squamous cell carcinoma; hTERT: Human telomerase reverse transcriptase.
Figure 2 Analysis of the FormulationDT artificial intelligence platform.
PU: Positive unlabeled.
Figure 3 Molecular structures of carrier/matrix materials for the licensed solid dispersion products.
PVP: Polyvinylpyrrolidone.
- Citation: Zhang XJ, Deng NX, Zhang HQ, Cen JZ, Zheng ZX, Guo MQ, Huang ZW. Solid dispersion of BIBR1532: A potent therapeutic for oesophageal squamous cancer. World J Gastrointest Oncol 2026; 18(1): 114924
- URL: https://www.wjgnet.com/1948-5204/full/v18/i1/114924.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i1.114924
